Literature DB >> 30484005

Interleukin (IL)-35 Suppresses IL-6 and IL-8 Production in IL-17A-Stimulated Human Periodontal Ligament Cells.

Satoru Shindo1, Yoshitaka Hosokawa2, Ikuko Hosokawa2, Hideki Shiba3.   

Abstract

Interleukin (IL)-35 is a novel anti-inflammatory cytokine that is produced by regulatory T cells. IL-35 is reported to suppress IL-17A-producing helper T (Th17) cell activation. IL-17A is related to progression of periodontitis. Furthermore, IL-35 and IL-17A are detected in human gingival crevicular fluid. However, the effect of IL-35 and interaction between IL-35 and IL-17A on pro-inflammatory cytokine production in human periodontal resident cells are still unclear. The aim of this study was to clarify the effect of IL-35 on IL-6 and IL-8 production in human periodontal ligament cells (HPDLCs) stimulated with IL-17A. IL-35 inhibited IL-6 and IL-8 production in IL-17A-stimulated HPDLCs. Moreover, western blot analysis showed that IL-35 suppressed extracellular signal-regulated kinase (ERK) and nuclear factor (NF)-κB p65 phosphorylation in IL-17A-stimulated HPDLCs. Our findings suggested that IL-35 produced from regulatory T cells might inhibit progression of periodontitis by decreasing IL-17A-induced levels of IL-6 and IL-8.

Entities:  

Keywords:  IL-17A; IL-35; IL-6; IL-8; human periodontal ligament cells

Year:  2019        PMID: 30484005     DOI: 10.1007/s10753-018-0938-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

1.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

Authors:  S Kotake; N Udagawa; N Takahashi; K Matsuzaki; K Itoh; S Ishiyama; S Saito; K Inoue; N Kamatani; M T Gillespie; T J Martin; T Suda
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Development, cytokine profile and function of human interleukin 17-producing helper T cells.

Authors:  Nicholas J Wilson; Katia Boniface; Jason R Chan; Brent S McKenzie; Wendy M Blumenschein; Jeanine D Mattson; Beth Basham; Kathleen Smith; Taiying Chen; Franck Morel; Jean-Claude Lecron; Robert A Kastelein; Daniel J Cua; Terrill K McClanahan; Edward P Bowman; Rene de Waal Malefyt
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

3.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

4.  The potential role of interleukin-17 in the immunopathology of periodontal disease.

Authors:  Keiso Takahashi; Takashi Azuma; Hitoshi Motohira; D F Kinane; Shin Kitetsu
Journal:  J Clin Periodontol       Date:  2005-04       Impact factor: 8.728

5.  IL-17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6/TBK1-JNK/NF-κB pathways.

Authors:  Danping Lin; Lu Li; Ying Sun; Weidong Wang; Xiaoqian Wang; Yu Ye; Xu Chen; Yan Xu
Journal:  Immunology       Date:  2014-09-29       Impact factor: 7.397

6.  Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17.

Authors:  Y-J Jung; Y-J Choi; S-J An; H-R Lee; H-K Jun; B-K Choi
Journal:  Mol Oral Microbiol       Date:  2016-09-13       Impact factor: 3.563

7.  IL-8 and TNF-alpha from peripheral neutrophils and acute-phase proteins in periodontitis.

Authors:  M Fredriksson; K Bergström; B Asman
Journal:  J Clin Periodontol       Date:  2002-02       Impact factor: 8.728

8.  Genipin inhibits IL-1β-induced CCL20 and IL-6 production from human periodontal ligament cells.

Authors:  Satoru Shindo; Yoshitaka Hosokawa; Ikuko Hosokawa; Kazumi Ozaki; Takashi Matsuo
Journal:  Cell Physiol Biochem       Date:  2014-02-06

9.  Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.

Authors:  Brian M Olson; Ewa Jankowska-Gan; Jordan T Becker; Dario A A Vignali; William J Burlingham; Douglas G McNeel
Journal:  J Immunol       Date:  2012-11-14       Impact factor: 5.422

10.  Effect of interleukin (IL)-35 on IL-17 expression and production by human CD4+ T cells.

Authors:  Kosuke Okada; Takeki Fujimura; Takeshi Kikuchi; Makoto Aino; Yosuke Kamiya; Ario Izawa; Yuki Iwamura; Hisashi Goto; Iichiro Okabe; Eriko Miyake; Yoshiaki Hasegawa; Makio Mogi; Akio Mitani
Journal:  PeerJ       Date:  2017-02-15       Impact factor: 2.984

View more
  4 in total

1.  Effect of nonsurgical periodontal therapy on gingival crevicular fluid levels of Interleukin-35 in patients with periodontitis.

Authors:  Arshiya Goswamy; Mayank Hans; Veenu Madaan Hans; Vidushi Sheokand; Harpreet Singh Grover
Journal:  J Oral Biol Craniofac Res       Date:  2022-03-16

2.  Potential therapeutic effects of interleukin-35 on the differentiation of naïve T cells into Helios+Foxp3+ Tregs in clinical and experimental acute respiratory distress syndrome.

Authors:  Chuanjiang Wang; Ke Xie; Kefeng Li; Shihui Lin; Fang Xu
Journal:  Mol Immunol       Date:  2021-01-16       Impact factor: 4.407

3.  Interleukin-35 pathobiology in periodontal disease: a systematic scoping review.

Authors:  Patrick R Schmidlin; Mandana Dehghannejad; Omid Fakheran
Journal:  BMC Oral Health       Date:  2021-03-20       Impact factor: 2.757

4.  Identification of microRNA-mRNA-TF regulatory networks in periodontitis by bioinformatics analysis.

Authors:  Xiaoli Gao; Dong Zhao; Jing Han; Zheng Zhang; Zuomin Wang
Journal:  BMC Oral Health       Date:  2022-04-09       Impact factor: 2.757

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.